These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [The effect of recombinant human erythropoietin on erythrocyte lines in patients with anemia and chronic renal insufficiency]. Marisavljević D; Djukanović Lj; Lezajić V Srp Arh Celok Lek; 1992; 120(9-10):281-5. PubMed ID: 1306020 [TBL] [Abstract][Full Text] [Related]
25. [Anemia in the dialyzed patient]. Deray G Soins; 2003 Oct; (679 Suppl):17. PubMed ID: 14621469 [No Abstract] [Full Text] [Related]
26. Recombinant erythropoietin for the anemia of chronic renal failure. Ahmad R; Hand M N Engl J Med; 1987 Jul; 317(3):169-70. PubMed ID: 3600706 [No Abstract] [Full Text] [Related]
27. [The abnormalities of blood cells in chronic kidney failure with long-term dialysis]. Narita M; Shibata A Nihon Rinsho; 1992 Jan; 50 Suppl():763-70. PubMed ID: 1578764 [No Abstract] [Full Text] [Related]
28. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients. Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762 [TBL] [Abstract][Full Text] [Related]
29. Erythropoietin: the promise and the facts. Eschbach JW Kidney Int Suppl; 1994 Jan; 44():S70-6. PubMed ID: 8127037 [No Abstract] [Full Text] [Related]
30. Update on erythropoietin. Fried W; Morley C Int J Artif Organs; 1985 Mar; 8(2):79-82. PubMed ID: 3886559 [No Abstract] [Full Text] [Related]
31. Clinical administration of epoetin alfa recombinant. Taylor BA; Weinstein SM J Intraven Nurs; 1992; 15(2):78-82. PubMed ID: 1564606 [TBL] [Abstract][Full Text] [Related]
32. Erythropoietin and the kidney. Fried W Nephron; 1975; 15(3-5):327-49. PubMed ID: 1101091 [TBL] [Abstract][Full Text] [Related]
33. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy]. Wiecek A Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683 [No Abstract] [Full Text] [Related]
34. Choice of erythropoiesis stimulating agent in ESRD. Fishbane S; Shah HH Nephrol News Issues; 2013 Jun; 27(7):Supp 10-2. PubMed ID: 23855143 [No Abstract] [Full Text] [Related]
35. Management of renal anemia. Peco-Antic A Turk J Pediatr; 2005; 47 Suppl():19-27. PubMed ID: 15884663 [TBL] [Abstract][Full Text] [Related]
36. Erythropoietin for the anemia of chronic renal failure. Schwartz AB; Prior J; Terzian L; Kahn B Am Fam Physician; 1988 Jun; 37(6):211-5. PubMed ID: 3289343 [No Abstract] [Full Text] [Related]
37. Erythropoietin for anemia of renal failure in sickle cell disease. Steinberg MH N Engl J Med; 1991 May; 324(19):1369-70. PubMed ID: 1759999 [No Abstract] [Full Text] [Related]
38. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin. Eschbach JW; Haley NR; Adamson JW Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841 [No Abstract] [Full Text] [Related]
39. [Erythropoietin in 1991--pathophysiological and therapeutic aspects]. Wiecek A Przegl Lek; 1992; 49(1-2):31-5. PubMed ID: 1455002 [No Abstract] [Full Text] [Related]
40. Dynamics of erythropoiesis following renal transplantation. Besarab A; Caro J; Jarrell BE; Francos G; Erslev AJ Kidney Int; 1987 Oct; 32(4):526-36. PubMed ID: 3323595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]